BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36068422)

  • 1. Integrated bioinformatics analysis and screening of hub genes in polycystic ovary syndrome.
    Qiao G; Xing J; Luo X; Zhang C; Yi J
    Endocrine; 2022 Dec; 78(3):615-627. PubMed ID: 36068422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Crucial lncRNAs, miRNAs, mRNAs, and Potential Therapeutic Compounds for Polycystic Ovary Syndrome by Bioinformatics Analysis.
    Zeng Z; Lin X; Xia T; Liu W; Tian X; Li M
    Biomed Res Int; 2020; 2020():1817094. PubMed ID: 33224973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycystic ovary syndrome: Identification of novel and hub biomarkers in the autophagy-associated mRNA-miRNA-lncRNA network.
    Huang J; Huang B; Kong Y; Yang Y; Tian C; Chen L; Liao Y; Ma L
    Front Endocrinol (Lausanne); 2022; 13():1032064. PubMed ID: 36523600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules.
    Devarbhavi P; Telang L; Vastrad B; Tengli A; Vastrad C; Kotturshetti I
    Reprod Biol Endocrinol; 2021 Feb; 19(1):31. PubMed ID: 33622336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Hub Genes and Biomarkers between Hyperandrogen and Normoandrogen Polycystic Ovary Syndrome by Bioinformatics Analysis.
    Zhang T; Liu Y; Li X; Hu B
    Comb Chem High Throughput Screen; 2023; 26(1):126-134. PubMed ID: 35379124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WGCNA Analysis Identifies Polycystic Ovary Syndrome-Associated Circular RNAs That Interact with RNA-Binding Proteins and Sponge miRNAs.
    Li M; Zeng Z; Zhang A; Ye Q; Su S; Xia T
    Int J Gen Med; 2021; 14():8737-8751. PubMed ID: 34849014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel candidate biomarkers and immune infiltration in polycystic ovary syndrome.
    Na Z; Guo W; Song J; Feng D; Fang Y; Li D
    J Ovarian Res; 2022 Jul; 15(1):80. PubMed ID: 35794640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated bioinformatics analysis elucidates granulosa cell whole-transcriptome landscape of PCOS in China.
    Li Q; Sang Y; Chen Q; Ye B; Zhou X; Zhu Y
    J Ovarian Res; 2023 Aug; 16(1):154. PubMed ID: 37537636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lncRNA-miRNA-mRNA ceRNA network in mural granulosa cells of patients with polycystic ovary syndrome: an analysis of Gene Expression Omnibus data.
    Chen H; Cheng S; Xiong W; Tan X
    Ann Transl Med; 2021 Jul; 9(14):1156. PubMed ID: 34430597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of labor related gene subtype classification on heterogeneity of polycystic ovary syndrome.
    Zhou J; Jiang Z; Fu L; Qu F; Dai M; Xie N; Zhang S; Wang F
    PLoS One; 2023; 18(3):e0282292. PubMed ID: 36857354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative Analysis of Core Genes and Biological Process Involved in Polycystic Ovary Syndrome.
    Zhang Y; Zhao T; Hu L; Xue J
    Reprod Sci; 2023 Oct; 30(10):3055-3070. PubMed ID: 37171773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of key genes and molecular pathways in type 2 diabetes mellitus and polycystic ovary syndrome via bioinformatics analyses.
    Zhang J; Zhang FJ; Zhang L; Xian DX; Wang SA; Peng M; Liu Y
    Eur Rev Med Pharmacol Sci; 2023 Apr; 27(8):3255-3269. PubMed ID: 37140276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microarray analysis of obese women with polycystic ovary syndrome for key gene screening, key pathway identification and drug prediction.
    Wei L; Xin C; Wang W; Hao C
    Gene; 2018 Jun; 661():85-94. PubMed ID: 29601948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the key pathways and genes related to polycystic ovary syndrome using bioinformatics analysis.
    Bi X; Zhai Z; Wang S
    Gen Physiol Biophys; 2019 May; 38(3):205-214. PubMed ID: 31184307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics-based analysis of potential therapeutic target genes for polycystic ovary syndrome.
    Liu Y; Yu J; Li J; Li W; Ma H
    Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):169-175. PubMed ID: 38678611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of key genes and miRNAs related to polycystic ovary syndrome by comprehensive analysis of microarray.
    Sun Z; Wang Y; Wei T; Liu L
    BMC Med Genomics; 2022 Dec; 15(1):267. PubMed ID: 36544152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of vital modules and genes associated with heart failure based on weighted gene coexpression network analysis.
    Bian W; Wang Z; Li X; Jiang XX; Zhang H; Liu Z; Zhang DM
    ESC Heart Fail; 2022 Apr; 9(2):1370-1379. PubMed ID: 35128826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Explore the potential molecular mechanism of polycystic ovarian syndrome by protein-protein interaction network analysis.
    Chen Q; Zheng B; Du S; Lin Y
    Taiwan J Obstet Gynecol; 2021 Sep; 60(5):807-815. PubMed ID: 34507653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weighted Gene Co-Expression Network Analysis (WGCNA) Discovered Novel Long Non-Coding RNAs for Polycystic Ovary Syndrome.
    Heidarzadehpilehrood R; Pirhoushiaran M; Binti Osman M; Abdul Hamid H; Ling KH
    Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Hub Genes Associated with Immune Infiltration in Cardioembolic Stroke by Whole Blood Transcriptome Analysis.
    Li Q; Gao X; Luo X; Wu Q; He J; Liu Y; Xue Y; Wu S; Rao F
    Dis Markers; 2022; 2022():8086991. PubMed ID: 35075378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.